|
EARNINGS REPORT by CSIMarket
EPS Drops, Sales very Strong
Yandex N V announced fiscal fourth quarter 2020 operating profit of $220 millions
![By_TIFFANY_DAWN_NICHOLSON_(TDNphoto)_(Flickr_Anna_checking_facebook)_[CC-BY-2.0_(http_creativecommons.org_licenses_by-2.0)]_via_Wikimedia_Commons.jpg](../news/img/computer/By_TIFFANY_DAWN_NICHOLSON_(TDNphoto)_(Flickr_Anna_checking_facebook)_[CC-BY-2.0_(http_creativecommons.org_licenses_by-2.0)]_via_Wikimedia_Commons.jpg "By_TIFFANY_DAWN_NICHOLSON_(TDNphoto)_(Flickr_Anna_checking_facebook)_[CC-BY-2.0_(http_creativecommons.org_licenses_by-2.0)]_via_Wikimedia_Commons.jpg") Yandex N V announced earnings per share of $0.98 and Sales of $0 millions in the fiscal fourth quarter 2020, Company's earnings per share plummeted by -51.96 % per share, versus $2.04 eps, earned in the same quarter a year ago, although Yandex N V saw it's Sales rise by 60.84 % in the same period. In contrast to the third quarter 2020 from $0 millions and from $0.00 per share. Net income of $326.900 millions in the fiscal fourth quarter 2020 fell by -50.48 % from $660.100 millions in the corresponding period a year before. Yandex N V shifted it's focus on improving sales in the fiscal fourth quarter 2020, as a result net margin eased to 11.06%. Looking into financial results for the fiscal year 2020, Yandex N V reported Sales of $ 2.96 billions and net income of $ 327 millions. Internet Services & Social Media Company explained also, that Income per share faded by -51.96 % to $0.98 per share from $2.04 in the previous fiscal year, while Sales surged by 60.84 % from $1.84 billions a year ago. Yandex N V is expected to report next financial results on September 24, 2021.
|
Recently Reported Results |
![closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Cytodyn inc
Yandex N V announced earnings per share of $0.98 and Sales of $0 millions in the fiscal fourth quarter 2020, Company's earnings per share plummeted by -51.96 % per share, versus $2.04 eps, earned in the same quarter a year ago, although Yandex N V saw it's Sales rise by 60.84 % in the same period.
Cytodyn Inc reported operating shortfall of $-30.785 millions, in the fiscal period ending Feb 28 2021, a deterioration from the operating shortfall of $-22.074684 millions, realized in third quarter of 2020
CYDY stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Producer Price Index
U.S. Producer price index continued to rise in February, but on the lower pace.
|
Enertopia Corp
Enertopia Corp announced operating loss of $-0.327792 millions, in the second quarter of 2021 earnings season, a change from the operating shortfall of $-0.055649 millions, recorded in the same quarter a year ago.
ENRT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Nanovation Microtech Inc
In the second quarter of 2021 Nanovation Microtech Inc loss increased of $-0.12 per share compared to $0.00 a year ago and improved from $-0.38 per share from the previous quarter.
Nanovation Microtech Inc reported operating loss of $-0.00423 millions, in the second quarter of 2021, an improvement from the operating shortfall of $-0.055649 millions, realized in second quarter of 2020
NANN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Messe_2012_by-RaBoe_127_Ra_Boe_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/manufacturing/Messe_2012_by-RaBoe_127_Ra_Boe_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Messe_2012_by-RaBoe_127_Ra_Boe_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Cannabics Pharmaceuticals Inc
In the financial second quarter of 2021 Cannabics Pharmaceuticals Inc reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Housing Starts
The construction of new homes, as well as the issuance of new building permits declined in February, signaling slowdown in economic growth and decrease in business profitability.
|
![Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/durable_goods/Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Durable Goods Orders
Durable Goods orders continued to grow, as bookings outgrow production.
|
Factory Orders
Factory orders continued to grow, as bookings outgrow production.
|
![women_app_By_J_P_Karna_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/apparel/women_app_By_J_P_Karna_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "women_app_By_J_P_Karna_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Citi Trends inc
Company displayed pleasant results in the fiscal fourth quarter of 2020. Sales were at $251.92 millions higher by 19.39% year on year and improved by 26.53 % quarter on quarter, while earnings per share more than doubled by 114.78 % to $1.80, sequentially eps more than doubled by 169.28 %.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.
Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
CTRN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Teardroppers Inc
Teardroppers Inc announced earnings per share of $-0.00 and Sales of $0.02 millions in the most recent fiscal period, Company's reached break-even per share, versus $-0.00 eps, earned in the same quarter a year ago, although Teardroppers Inc saw its Sales rise by 50.85% in the same period.
In contrast to the third quarter Sales increased by 3.89 % from $0.02 millions and from $0.00 per share.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.
Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
TRDP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Genethera Inc
In the fiscal fourth quarter of 2020 Genethera Inc reached break-even of $-0.00 per share compared to $-0.01 a year ago and from $-0.01 per share from the previous quarter.
Genethera Inc reported operating deficit of $-0.132123 millions, in the fiscal fourth quarter of 2020, an improvement from the operating loss of $-0.239101 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GTHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
High Sierra Technologies Inc
In the financial time frame ending Dec 31 2020 High Sierra Technologies Inc increased losses of $-0.01 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.
High Sierra Technologies Inc reported operating shortfall of $-0.187955 millions, in the financial time frame ending Dec 31 2020, a deterioration from the operating income of $0.012858 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GLFO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/realestate/HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Eaco Corp
Eaco Corp realized a deterioration in earnings per share by -47.17% to $0.28 and Sales decrease by -1.9% to $55.75 millions in the second quarter of 2021, year on year.
From the preceding quarter, eps soared from $0.17 per share and Sales increased by 4.4 % from $53.40 millions.
EACO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![HK_ICC_Imperial_Cullinan_showflats_By_Keithmenorm_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/realestate/HK_ICC_Imperial_Cullinan_showflats_By_Keithmenorm_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "HK_ICC_Imperial_Cullinan_showflats_By_Keithmenorm_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Cannapharmarx Inc
Company reports $-11.55 million loss, as impairment charges strip off $6.03 million from the fiscal time frame ending Dec 31 2020 results.
Cannapharmarx Inc reported operating loss of $-9.815889 millions, in the fiscal time frame ending Dec 31 2020, a deterioration from the operating shortfall of $-7.985159 millions, realized in fourth quarter of 2019
Cannapharmarx Inc reported net loss of $-19.89 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.49 from $-0.66 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
CPMD stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|
